Banco Santander, S.A. Seagen Inc. Transaction History

Banco Santander, S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$108.81 - $179.33 $1.63 Million - $2.69 Million	15,000 New	15,000 $2.65 Million
Q1 2021 May 10, 2021	SELL	$137.51 - $190.8 $180,963 - $251,092	-1,316 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $216,653 - $278,899	1,316 New	1,316 $230,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Santander, S.A. with notifications on news.